Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
Pharmacy raided in Ozempic crackdown A large quantity of semaglutide was seized from a Melbourne chemist as part of a TGA probe into alleged manufacturing of copycat drugs.
GP concern over new Ozempic copycat Telehealth start-up Eucalyptus will soon start selling compounded semaglutide, amid a worldwide shortage of the viral drug.
Diabetes medication shortage worsens Access to treatment is becoming increasingly dire for patients, with GPs predicting a shortage of tirzepatide will add to an already long list of supply issues.
Viral weight loss drug linked to pancreatitis Semaglutide could be putting patients at greater risk of severe gastrointestinal complications when used for obesity management.
Do not initiate new patients on semaglutide: TGA The medication is again in short supply due to off-label prescribing for weight loss, despite only being approved for type 2 diabetes management.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
Telehealth provider defies TGA semaglutide request Eucalyptus is reportedly offering patients access to the type 2 diabetes-indicated drug for weight loss purposes, despite ongoing supply issues.
Warning over fake semaglutide Counterfeit products are being illegally imported into Australia, TGA testing has revealed.
Intermittent semaglutide availability until at least June Supply issues will remain while the medicine’s sponsor ‘continues to build stable stock supplies over coming weeks and months’.